Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors Yoshiyuki Sato, Yu Onozaki, et al. Bioorg. Med. Chem. Lett 2009;19:4673–4678
Multifaceted polo-like kinases:drug targets and antitargets for cancer therapy Klaus Strebhardt Drug Discovery AuguST 2010;9:643-660
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.